Stock Track | Savara Inc Soars 6.32% Pre-market on Multiple Analyst Upgrades and Price Target Increases

Stock Track

08/15

Savara Inc (SVRA) shares are surging 6.32% in pre-market trading on Friday, following a series of analyst upgrades and price target increases. The biotech company has attracted positive attention from Wall Street, with multiple firms expressing optimism about its prospects.

H.C. Wainwright made a significant move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited the company's alignment on resubmission prospects as a key factor in the upgrade. Meanwhile, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further boosting investor confidence.

The overall sentiment among analysts remains bullish, with Savara maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1110452634"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1110452634\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1110452634?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-15 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110452634","market":"nz","top_or_hot":-1,"title":"Stock Track | Savara Inc Soars 6.32% Pre-market on Multiple Analyst Upgrades and Price Target Increases","media":"Stock Track","content":"<p>Savara Inc (SVRA) shares are surging 6.32% in pre-market trading on Friday, following a series of analyst upgrades and price target increases. The biotech company has attracted positive attention from Wall Street, with multiple firms expressing optimism about its prospects.</p>\n\n<p>H.C. Wainwright made a significant move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited the company's alignment on resubmission prospects as a key factor in the upgrade. Meanwhile, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further boosting investor confidence.</p>\n\n<p>The overall sentiment among analysts remains bullish, with Savara maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Savara Inc Soars 6.32% Pre-market on Multiple Analyst Upgrades and Price Target Increases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Savara Inc Soars 6.32% Pre-market on Multiple Analyst Upgrades and Price Target Increases\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-08-15 21:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Savara Inc (SVRA) shares are surging 6.32% in pre-market trading on Friday, following a series of analyst upgrades and price target increases. The biotech company has attracted positive attention from Wall Street, with multiple firms expressing optimism about its prospects.</p>\n\n<p>H.C. Wainwright made a significant move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited the company's alignment on resubmission prospects as a key factor in the upgrade. Meanwhile, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further boosting investor confidence.</p>\n\n<p>The overall sentiment among analysts remains bullish, with Savara maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SVRA","symbol_name":"Savara Inc","start_time":0,"source_url":"","article_id":"1110452634","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110452634","pubTimestamp":1755264261,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Savara Inc (SVRA) shares are surging 6.32% in pre-market trading on Friday, following a series of analyst upgrades and price target increases. The biotech company has attracted positive attention...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SVRA":"Savara Inc"},"translate_title":"个股追踪|Savara Inc盘前大涨6.32%，多位分析师上调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SVRA":1},"content_text":"Savara Inc (SVRA) shares are surging 6.32% in pre-market trading on Friday, following a series of analyst upgrades and price target increases. The biotech company has attracted positive attention from Wall Street, with multiple firms expressing optimism about its prospects.\nH.C. Wainwright made a significant move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited the company's alignment on resubmission prospects as a key factor in the upgrade. Meanwhile, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further boosting investor confidence.\nThe overall sentiment among analysts remains bullish, with Savara maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}